SBARRO HEALTH RES ORGANIZATION has a total of 11 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), Canada and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are IMBA INST FÜR MOLEKULARE BIOTECHNOLOGIE GMBH, HUANG WENLIN and PROCURE THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Canada | 2 | |
#3 | United States | 2 | |
#4 | Hong Kong | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Measuring microorganism processes | |
#5 | Peptides | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Giordano Antonio | 9 |
#2 | Giovan Giacomo Giordano | 2 |
#3 | Tosi Piero | 2 |
#4 | Giacinti Cristina | 1 |
Publication | Filing date | Title |
---|---|---|
US2009285791A1 | Regenerating and enhancing development of muscle tissue | |
US2008124314A1 | Peptide inhibitors of cyclin-dependent kinase activity and uses thereof | |
EP1789581A1 | Methods for determining presence of cancer by analyzing the expression of cdk9 and/or cyclin t1 in lymphoid tissue | |
EP1424894A2 | Inhibition of pathological angiogenesis in vivo |